Discover 10 top high-yield dividend stocks for April 2025. With a 5.30% yield & 8.33% growth rate, learn how to build wealth ...

Major pharmaceutical companies reap most of their profits in the U.S. but shift their tax burdens to low-tax havens such as ...

Formation Bio, an AI-driven pharmaceutical company revolutionizing drug development, today announced that Mikael Dolsten, MD, PhD, former Chief Scientific Officer and President, Pfizer Research & ...

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

With the recently announced layoffs of 3,500 FDA staffers and exits of branch directors Patrizia Cavazzoni and Peter Marks, ...

A pair of top Democratic lawmakers asked the U.S. securities regulator on Wednesday to preserve records related to President ...

Institutional Shareholder Services has recommended Pfizer investors reject a proposal on executive compensation at its ...

(Reuters) -Institutional Shareholder Services has recommended Pfizer investors reject a proposal on executive compensation ...

In a report released today, Geoff Meacham from Citi maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $27.00.

Pfizer delayed the announcement of its COVID-19 vaccine until after the 2020 election when it thought Donald Trump was ...

Perhaps the Tuesday pharma sell-off was mitigated by indications Trump and his team might be amenable to either a softer or more gradual approach to industry tariffs. That bearishness about the ...